Literature DB >> 1902657

The use of albumin in clinical practice.

B L Erstad1, B J Gales, W D Rappaport.   

Abstract

The use of albumin in the clinical setting continues to generate controversy. Periodic shortages and the high cost of albumin have compelled many hospitals to develop guidelines regarding albumin administration. Our purpose is to review the human studies involving albumin. Particular emphasis will be placed on comparative trials involving albumin and the less expensive crystalloid solutions. It is hoped that this review will assist the clinician in making judgements concerning the appropriate use of albumin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902657

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  Initial resuscitation and management of pediatric septic shock.

Authors:  K Martin; S L Weiss
Journal:  Minerva Pediatr       Date:  2015-01-21       Impact factor: 1.312

2.  Analbuminemia: three cases resulting from different point mutations in the albumin gene.

Authors:  S Watkins; J Madison; M Galliano; L Minchiotti; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

3.  Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial.

Authors:  Thiemo F Veneman; Jeroen Oude Nijhuis; Arend J J Woittiez
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

4.  Production of recombinant albumin by a herd of cloned transgenic cattle.

Authors:  Yann Echelard; Jennifer L Williams; Margaret M Destrempes; Julie A Koster; Susan A Overton; Daniel P Pollock; Karen T Rapiejko; Esmail Behboodi; Nicholas C Masiello; William G Gavin; Jerry Pommer; Scott M Van Patten; David C Faber; Jose B Cibelli; Harry M Meade
Journal:  Transgenic Res       Date:  2008-11-22       Impact factor: 2.788

5.  Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial.

Authors:  Roberto-Giulio Romanelli; Giorgio La Villa; Giuseppe Barletta; Francesco Vizzutti; Fabio Lanini; Umberto Arena; Vieri Boddi; Roberto Tarquini; Pietro Pantaleo; Paolo Gentilini; Giacomo Laffi
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

6.  Assessment of the immunogenicity of residual host cell protein impurities of OsrHSA.

Authors:  Naghmeh Abiri; Jianlei Pang; Jiquan Ou; Bo Shi; Xianghong Wang; Sucai Zhang; Yunxia Sun; Daichang Yang
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

7.  Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock.

Authors:  Chenglong Ge; Qianyi Peng; Wei Chen; Wenchao Li; Lina Zhang; Yuhang Ai
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.